现如今,经动脉化疗栓塞术(transarterial chemoembolization, TACE)已经成为中晚期肝细胞癌(hepatocellular carcinoma, HCC)主要的治疗方式,但是术后的复发率依然较高,TACE术前肿瘤的全面评估以及术后早期的疗效预测显得尤为重要,随着医学影像学技术、人工智能以及分子生物学的不断发展,肝癌患者术后早期疗效评估成为研究热点,本文就肝癌患者在接受TACE术后对于早期疗效预测价值的研究进展进行综述。
Nowadays, transarterial chemoembolization (TACE) has become the main treatment for middle- advanced hepatocellular carcinoma (HCC), but the recurrence rate is still high. Comprehensive evaluation of tumor before TACE and early prediction of efficacy after TACE are particularly im-portant. With the continuous development of medical imaging technology, artificial intelligence and molecular biology, the evaluation of early efficacy after hepatocellular carcinoma surgery has be-come a research hotspot. This article reviews the research progress on the predictive value of early efficacy in patients with HCC after TACE.
磁共振成像,钆塞酸二钠,经动脉化疗栓塞术, Magnetic Resonance Imaging Gd-EOB-DTPA Transarterial Chemoembolization摘要
Nowadays, transarterial chemoembolization (TACE) has become the main treatment for middle-advanced hepatocellular carcinoma (HCC), but the recurrence rate is still high. Comprehensive evaluation of tumor before TACE and early prediction of efficacy after TACE are particularly important. With the continuous development of medical imaging technology, artificial intelligence and molecular biology, the evaluation of early efficacy after hepatocellular carcinoma surgery has become a research hotspot. This article reviews the research progress on the predictive value of early efficacy in patients with HCC after TACE.
刘志祥,尹桂秀. 肝细胞癌TACE术后早期疗效预测价值的研究进展Research Progress on the Predictive Value of Early Curative Effect after TACE for Hepatocellular Carcinoma[J]. 临床医学进展, 2022, 12(11): 10342-10350. https://doi.org/10.12677/ACM.2022.12111491
参考文献ReferencesDimitroulis, D., Damaskos, C., Valsami, S., Davakis, S., Garmpis, N., Spartalis, E., Athanasiou, A., Moris, D., Sakel-lariou, S., Kykalos, S., Tsourouflis, G., Garmpi, A., Delladetsima, I., Kontzoglou, K. and Kouraklis, G. (2017) From Diagnosis to Treatment of Hepatocellular Carcinoma: An Epidemic Problem for both Developed and Developing World. World Journal of Gastroenterology, 23, 5282-5294. <br>https://doi.org/10.3748/wjg.v23.i29.5282Kanwal, F. and Singal, A.G. (2019) Surveillance for Hepatocellular Carcinoma: Current Best Practice and Future Direction. Gastroenter-ology, 157, 54-64. <br>https://doi.org/10.1053/j.gastro.2019.02.049Kim, J.H., Sinn, D.H., Shin, S.W., Cho, S.K., Kang, W., Gwak, G.Y., Paik, Y.H., Lee, J.H., Koh, K.C., Paik, S.W. and Choi, M.S. (2017) The Role of Scheduled Second TACE in Early-Stage Hepatocellular Carcinoma with Complete Response to Initial TACE. Clinical and Molecu-lar Hepatology, 23, 42-50. <br>https://doi.org/10.3350/cmh.2016.0058Eggert, T. and Greten, T.F. (2017) Current Standard and Future Perspectives in Non-Surgical Therapy for Hepatocellular Carcinoma. Digestion, 96, 1-4. <br>https://doi.org/10.1159/000464282Moustafa, A.S., Abdel Aal, A.K., Ertel, N., Saad, N., DuBay, D. and Saddekni, S. (2017) Chemoembolization of Hepatocellular Carcinoma with Extrahepatic Collateral Blood Supply: Ana-tomic and Technical Considerations. Radiographics: A Review Publication of the Radiological Society of North America, Inc, 37, 963-977.
<br>https://doi.org/10.1148/rg.2017160122Forner, A., Reig, M.E., de Lope, C.R. and Bruix, J. (2010) Current Strategy for Staging and Treatment: The BCLC Update and Future Prospects. Seminars in Liver Disease, 30, 61-74. <br>https://doi.org/10.1055/s-0030-1247133陈磊, 陈诗, 郑传胜. 肝细胞癌经动脉化疗栓塞术后疗效预测的研究进展[J]. 影像诊断与介入放射学, 2019, 28(6): 445-450.Ronot, M., Purcell, Y. and Vilgrain, V. (2019) Hepatocellular Carcinoma: Current Imaging Modalities for Diagnosis and Prognosis. Digestive Diseases and Sciences, 64, 934-950. <br>https://doi.org/10.1007/s10620-019-05547-0何慧洲, 程芝梅, 张帅, 王黎洲, 李苒, 许敏, 周石. 剪切波弹性成像评价VX2肝癌模型兔TACE后瘤周纤维化[J]. 中国介入影像与治疗学, 2022, 19(8): 502-507.Zheng, J., Guo, H., Zeng, J., Huang, Z., Zheng, B., Ren, J., Xu, E., Li, K. and Zheng, R. (2015) Two-Dimensional Shear-Wave Elastography and Conventional US: The Optimal Evaluation of Liver Fibrosis and Cir-rhosis. Radiology, 275, 290-300. <br>https://doi.org/10.1148/radiol.14140828姜婷婷, 牟培源, 段伟宏, 刘全达, 白媛媛, 雷磊. TACE联合超声引导经皮微波消融治疗术后复发性肝细胞癌的临床研究[J]. 暨南大学学报(自然科学与医学版), 2022, 43(3): 284-292.Brown, D.B., Nikolic, B., Covey, A.M., Nutting, C.W., Saad, W.E., Salem, R., Sofocleous, C.T., Sze, D.Y. and Society of Interventional Radiology Standards of Practice Committee (2012) Quality Improvement Guidelines for Transhepatic Arterial Chemoembolization, Embolization, and Chemotherapeutic Infusion for Hepatic Malignancy. Journal of Vascular and Interventional Radiology: JVIR, 23, 287-294. <br>https://doi.org/10.1016/j.jvir.2011.11.029Bargellini, I., Bozzi, E., Campani, D., Carrai, P., De Simone, P., Pollina, L., Cioni, R., Filipponi, F. and Bartolozzi, C. (2013) Modified RECIST to Assess Tumor Response after Transarterial Chemoembolization of Hepatocellular Carcinoma: CT-Pathologic Correlation in 178 Liver Explants. Euro-pean Journal of Radiology, 82, e212-e218.
<br>https://doi.org/10.1016/j.ejrad.2012.12.009Takizawa, K., Numata, K., Morimoto, M., Kondo, M., Nozaki, A., Moriya, S., Ishii, T., Oshima, T., Fukuda, H., Okada, M., Takebayashi, S., Maeda, S. and Tanaka, K. (2013) Use of Contrast-Enhanced Ultrasonography with a Perflubutane-Based Contrast Agent Performed One Day after Transarterial Chemoembolization for the Early Assessment of Residual Viable Hepatocellular Carcinoma. European Journal of Radi-ology, 82, 1471-1480.
<br>https://doi.org/10.1016/j.ejrad.2013.04.045Watanabe, Y., Ogawa, M., Kumagawa, M., Hirayama, M., Miura, T., Matsumoto, N., Nakagawara, H., Yamamoto, T. and Moriyama, M. (2020) Utility of Contrast-Enhanced Ultrasound for Early Therapeutic Evaluation of Hepatocellular Carcinoma after Transcatheter Arterial Chemoembolization. Journal of Ultrasound in Medicine: Official Journal of the American Institute of Ultrasound in Medicine, 39, 431-440. <br>https://doi.org/10.1002/jum.15118Cao, J., Dong, Y., Fan, P., Mao, F., Chen, K., Chen, R., Huang, B., Cheng, Y. and Wang, W.P. (2021) Early Evaluation of Treatment Response to Transarterial Chemoembolization in Patients with Advanced Hepatocellular Carcinoma: The Role of Dynamic Three-Dimensional Contrast-Enhanced Ultrasound. Clinical Hemorheology and Microcirculation, 78, 365-377. <br>https://doi.org/10.3233/CH-201086Salvaggio, G., Campi-si, A., Lo Greco, V., Cannella, I., Meloni, M.F. and Caruso, G. (2010) Evaluation of Posttreatment Response of Hepato-cellular Carcinoma: Comparison of Ultrasonography with Second-Generation Ultrasound Contrast Agent and Multide-tector CT. Abdominal Imaging, 35, 447-453. <br>https://doi.org/10.1007/s00261-009-9551-6Zhao, R., Gong, X.J., Ge, Y.Q., Zhao, H., Wang, L.S., Yu, H.Z. and Liu, B. (2021) Use of Texture Analysis on Noncontrast MRI in Classifi-cation of Early Stage of Liver Fibrosis. Canadian Journal of Gastroenterology & Hepatology, 2021, Article ID: 6677821. <br>https://doi.org/10.1155/2021/6677821万小婷, 包晗, 黎超, 等. CT纹理分析与肝癌病理分化程度的相关性研究[J]. 临床放射学杂志, 2019, 38(7): 1239-1244.Wang, L.L., Li, J.F., Lei, J.Q., Guo, S.L., Li, J.K., Xu, Y.S. and Dou, Y. (2021) The Value of the Signal Intensity of Peritumoral Tissue on Gd-EOB-DTPA Dynamic Enhanced MRI in Assessment of Microvascular Invasion and Pathological Grade of Hepatocellular Carcinoma. Medicine, 100, e25804. <br>https://doi.org/10.1097/MD.0000000000025804岑永义, 农海洋, 李传, 梁克, 鲍保成, 陆玉敏. 基于CT增强扫描动脉期图像的纹理分析在肝细胞癌病理分化程度预测中的价值研究[J]. 临床放射学杂志, 2022, 41(8): 1476-1481.
<br>https://doi.org/10.13437/j.cnki.jcr.2022.08.039张月, 黄顺根, 蒋震, 盛茂, 郭万亮. 增强CT纹理分析预测肝细胞癌病理分级的价值[J]. 影像诊断与介入放射学, 2022, 31(3): 163-168.Park, H.J., Kim, J.H., Choi, S.Y., Lee, E.S., Park, S.J., Byun, J.Y. and Choi, B.I. (2017) Prediction of Therapeutic Response of Hepatocellular Car-cinoma to Transcatheter Arterial Chemoembolization Based on Pretherapeutic Dynamic CT and Textural Findings. AJR. American Journal of Roentgenology, 209, W211-W220.
<br>https://doi.org/10.2214/AJR.16.17398郑小敏, 曹锋, 钱立庭, 王传彬, 董江宁. 定量CT身体组分分析预测肝细胞癌经导管动脉化疗栓塞术治疗预后的研究[J]. 中华放射学杂志, 2021, 55(4): 371-376.王砚亮, 宋威, 卞益同, 张小彪, 李发中. CT量化碘油摄取预测原发性肝癌TACE术后肿瘤复发的临床价值[J]. 临床放射学杂志, 2020, 39(3): 573-578. <br>https://doi.org/10.13437/j.cnki.jcr.2020.03.033Watanabe, Y., Ogawa, M., Kaneko, M., Kumagawa, M., Hirayama, M., Matsumoto, N., Nakagawara, H., Yamamoto, T. and Moriyama, M. (2021) Comparison of Local Recurrence in Transcatheter Arterial Chemoembolization of Hepatocellular Carcinoma with or without Accumulation of Iodized Oil beyond Corona Enhancement Area: Short-Term Results. Radiology and Oncology, 56, 69-75. <br>https://doi.org/10.2478/raon-2021-0047Miyayama, S., Yamashiro, M., Nagai, K., Tohyama, J., Kawamura, K., Yoshida, M. and Sakuragawa, N. (2016) Evaluation of Tumor Recurrence after Superselective Conven-tional Transcatheter Arterial Chemoembolization for Hepatocellular Carcinoma: Comparison of Computed Tomography and Gadoxetate Disodium-Enhanced Magnetic Resonance Imaging. Hepatology Research: The Official Journal of the Japan Society of Hepatology, 46, 890-898.
<br>https://doi.org/10.1111/hepr.12632Imai, Y., Katayama, K., Hori, M., Yakushijin, T., Fujimoto, K., Itoh, T., Igura, T., Sakakibara, M., Takamura, M., Tsurusaki, M., Takahashi, H., Nakanishi, K., Usuki, N., Tsuji, K., Ohashi, H., Kim, T., Takehara, T. and Murakami, T. (2017) Prospective Comparison of Gd-EOB-DTPA-Enhanced MRI with Dy-namic CT for Detecting Recurrence of HCC after Radiofrequency Ablation. Liver Cancer, 6, 349-359. <br>https://doi.org/10.1159/000481416Palmucci S. (2014) Focal Liver Lesions Detection and Characterization: The Advantages of Gadoxetic Acid-Enhanced Liver MRI. World Journal of Hepatology, 6, 477-485. <br>https://doi.org/10.4254/wjh.v6.i7.477Ueno, A., Masugi, Y., Yamazaki, K., Komuta, M., Effendi, K., Tanami, Y., Tsujikawa, H., Tanimoto, A., Okuda, S., Itano, O., Kitagawa, Y., Kuribayashi, S. and Sakamoto, M. (2014) OATP1B3 Expression Is Strongly Associated with Wnt/β-Catenin Signalling and Represents the Transporter of Gadox-etic Acid in Hepatocellular Carcinoma. Journal of Hepatology, 61, 1080-1087. <br>https://doi.org/10.1016/j.jhep.2014.06.008Inchingolo, R., Faletti, R., Grazioli, L., Tricarico, E., Gatti, M., Pecorelli, A. and Ippolito, D. (2018) MR with Gd- EOB-DTPA in Assessment of Liver Nodules in Cirrhotic Patients. World Journal of Hepatology, 10, 462-473.
<br>https://doi.org/10.4254/wjh.v10.i7.462Zhao, Q.Y., Liu, S.S. and Fan, M.X. (2022) Prediction of Early Re-currence of Hepatocellular Carcinoma after Resection Based on Gd-EOB-DTPA Enhanced Magnetic Resonance Imaging: A Preliminary Study. Journal of Gastrointestinal Oncology, 13, 792-801. <br>https://doi.org/10.21037/jgo-22-224Chu, T., Zhao, C., Zhang, J., Duan, K., Li, M., Zhang, T., Lv, S., Liu, H. and Wei, F. (2022) Application of a Convolutional Neural Network for Multitask Learning to Simultaneously Predict Microvascular Invasion and Vessels That Encapsulate Tumor Clusters in Hepatocellular Carcinoma. Annals of Surgical Oncology, 29, 6774-6783.
<br>https://doi.org/10.1245/s10434-022-12000-6谢彩琴. Gd-EOB-DTPA MRI纹理分析在预测肝癌TACE术后早期疗效的初步研究[D]: [博士学位论文]. 广州: 南方医科大学, 2018.Park, S., Kim, T.S., Kang, S.H., Kim, H.B., Park, J.W., et al. (2018) 11C-Acetate and 18F-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography Dual Imaging for the Prediction of Response and Prognosis after Transarterial Chemoembolization. Medi-cine, 97, e12311. <br>https://doi.org/10.1097/MD.0000000000012311张穹, 刘纯, 陈明, 彭珍珍. 肝细胞癌TACE术后病灶存活或复发~(18)F-FDG PET/CT和增强CT诊断价值Meta分析[J]. 中华肿瘤防治杂志, 2021, 28(4): 302-309. <br>https://doi.org/10.16073/j.cnki.cjcpt.2021.04.10Lin, Y.Y., Lee, R.C., Guo, W.Y., Chu, W.F., Wu, F.C. and Gehrisch, S. (2016) Quantitative Real-Time Fluoroscopy Analysis on Measurement of the Hepatic Arterial Flow During Transcatheter Arterial Chemoembolization of Hepatocellular Carcinoma: Comparison with Quantitative Digital Subtraction Angiography Analysis. Cardiovascular and Interventional Radiology, 39, 1557-1563. <br>https://doi.org/10.1007/s00270-016-1421-3Wong, R.J., Ahmed, A. and Gish, R.G. (2015) Elevated Al-pha-Fetoprotein: Differential Diagnosis-Hepatocellular Carcinoma and Other Disorders. Clinics in Liver Disease, 19, 309-323. <br>https://doi.org/10.1016/j.cld.2015.01.005Prateepchaiboon, T., Chang, A., Pungpipattrakul, N., Akarapatima, K., Rattanasupar, A., Songjamrat, A., Pakdeejit, S. and Piratvisuth, T. (2022) Factors Affecting Prognosis in Hepatocellular Carcinoma Patients Post-Transarterial Chemoembolization. Indian Journal of Gastroenterology: Official Journal of the Indian Society of Gastroenterology, 41, 352-361. <br>https://doi.org/10.1007/s12664-021-01227-y魏建筑, 谭玉林. 甲胎蛋白异质体3在肝细胞癌肝动脉化疗栓塞术疗效评价中的价值[J]. 中国肿瘤临床与康复, 2016, 23(7): 810-813. <br>https://doi.org/10.13455/j.cnki.cjcor.2016.07.12Huang, C., Sheng, S., Sun, X., Liu, J. and Huang, G. (2014) Lens Culinaris Agglutinin-Reactive α-Fetoprotein Decline after Transcatheter Arterial Chemoem-bolization in Patients with Hepatocellular Carcinoma Predicts Survival. International Journal of Clinical Chemistry, 431, 232-238. <br>https://doi.org/10.1016/j.cca.2014.02.009Yang, X.G., Huang, Y.C., Wang, C.H., Sun, Y.Y., Huang, Z. and Xu, G.H. (2022) Predictive Value of Preoperative Neutrophil-to-Lymphocyte Ratio in Patients with Hepatocellular Carcinoma after Transarterial Chemoembolization Combined with Radiofrequency Ablation. Cancer Investigation, 40, 494-504.
<br>https://doi.org/10.1080/07357907.2022.2065508Cho, E.J., Yu, S.J., Lee, Y.B., Lee, J.H., Kim, Y.J. and Yoon, J.H. (2022) Prognostic Values of Inflammation-Based Scores and Fibrosis Markers in Patients with Hepatocellu-lar Carcinoma Treated with Transarterial Chemoembolization. Diagnostics (Basel, Switzerland), 12, Article No. 1170. <br>https://doi.org/10.3390/diagnostics12051170刘秀峰, 张珏, 姚琳, 杨朝旭. 中晚期肝细胞癌靶向联合免疫治疗进展[J]. 临床肝胆病杂志, 2022, 38(5): 992-997.傅煜, 符爽, 张继红. 核不均一核糖核蛋白L在肿瘤中作用机制的研究进展[J]. 中国医科大学学报, 2022, 51(9): 845-849.石旭, 葛勇胜, 荚卫东, 王涛, 任超. hnRNP L在肝癌中的表达及与巨噬细胞极化相关性研究[J]. 安徽医科大学学报, 2019, 54(10): 1601-1606. <br>https://doi.org/10.19405/j.cnki.issn1000-1492.2019.10.021Yau, W.Y., Shih, H.C., Tsai, M.H., Sheu, J.C., Chen, C.H. and Chow, L.P. (2013) Autoantibody Recognition of an N-Terminal Epitope of hnRNP L Marks the Risk for Developing HBV-Related Hepatocellular Carcinoma. Journal of Proteomics, 94, 346-358. <br>https://doi.org/10.1016/j.jprot.2013.10.003谢宇端, 董国伟, 韩艳, 何生奇. 环状RNA_0003028靶向微小RNA-498调控生殖器形成抑制基因-1/p53信号通路对人肝癌细胞系Huh7的影响[J]. 解剖学报, 2022, 53(5): 600-606.
<br>https://doi.org/10.16098/j.issn.0529-1356.2022.05.009刘旭初, 覃世运, 陈丽君, 陈娟, 尤晓光. KRAS基因突变对经肝动脉化疗栓塞术治疗的中晚期原发性肝癌患者预后的预测价值[J/OL]. 临床肝胆病杂志, 1-6.
http://kns.cnki.net/kcms/detail/22.1108.R.20220928.1040.002.html, 2022-10-04.Sun, L., Mu, L., Zhou, J., Tang, W., Zhang, L., Xie, S., Chen, J. and Wang, J. (2022) Imaging Features of Gadoxetic Acid-Enhanced MR Imaging for Evaluation of Tumor-Infiltrating CD8 Cells and PD-L1 Expression in Hepatocellular Carcinoma. Cancer Immunology, Immunotherapy: CII, 71, 25-38. <br>https://doi.org/10.1007/s00262-021-02957-wLlovet, J.M. and Lencioni, R. (2020) mRECIST for HCC: Performance and Novel Refinements. Journal of Hepatology, 72, 288-306. <br>https://doi.org/10.1016/j.jhep.2019.09.026Liao, H., Zhang, Z., Chen, J., Liao, M., Xu, L., Wu, Z., Yuan, K., Song, B. and Zeng, Y. (2019) Preoperative Radiomic Approach to Evaluate Tumor-Infiltrating CD8+ T Cells in Hepato-cellular Carcinoma Patients Using Contrast-Enhanced Computed Tomography. Annals of Surgical Oncology, 26, 4537-4547.
<br>https://doi.org/10.1245/s10434-019-07815-9张坤, 谢双双, 沈文. MRI影像组学在肝细胞癌诊疗和预后评估中的研究进展[J]. 国际医学放射学杂志, 2022, 45(4): 454-458. <br>https://doi.org/10.19300/j.2022.Z19770